The ethics around testing for Alzheimer’s


Guests: Dena Davis and Jason Karlawish

If you could have a blood test to find out your chances of developing Alzheimer’s, would you? And if that test revealed that you would be diagnosed with the disease in just a few years, what would you do? Would you consider ending your life before you becoming incapable of making decisions about the care you receive? While there is no effective treatment for Alzheimer’s, scientists are getting closer to identifying the markers and warning signs of the disease. But such testing raises interesting ethical issues for patients and their families, and health providers and researchers according to our guests, bioethicists DENA DAVIS and JASON KARLAWISH. Davis is a professor of bioethics at Lehigh University and Karlawish is a professor of medicine, medical ethics and health policy at the University of Pennsylvania

WHYY is your source for fact-based, in-depth journalism and information. As a nonprofit organization, we rely on financial support from readers like you. Please give today.

Want a digest of WHYY’s programs, events & stories? Sign up for our weekly newsletter.

Together we can reach 100% of WHYY’s fiscal year goal